Dr. Cheng is the Founder and President of AllClev Tech, Inc.  He holds an M.D and a Ph.D. and is the sole inventor of several U.S. patent-pending artificial intelligence (AI) technologies for healthcare, medical applications, and clinical research, as well as an AI-powered device that assists individuals with disabilities.

Over the course of his career, he has held executive leadership roles, including President, Chief Executive Officer (CEO), Chief Medical Officer (CMO), Chief Scientific Officer (CSO), Director, and Senior Vice President (SVP) of Translational Medicine, across organizations ranging from startups to S&P 100 companies. 

Prior to his enterprise leadership career, Dr. Cheng held a faculty role at University of Maryland School of Medicine, driving research in immunomodulation.  With over 25 years of experience, he brings expertise across the drug development lifecycle, spanning clinical research, translational medicine, and R&D in oncology, vaccines, neurology, immunology, cell and gene therapy, transplantation, and cardiovascular disease. He also applies Quantum Biology to advance transformative therapies and has authored over 90 publications. 

Dr. Cheng specialized in postdoctoral research in Biochemistry and Molecular Biology at Northwestern University, Chicago, USA, under the mentorship of a member of the U.S. National Academy of Sciences (NAS).